𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Impaired activating receptor expression pattern in natural killer cells from patients with multiple myeloma

✍ Scribed by Fauriat, C; Mallet, F; Olive, D; costello, R T

Book ID
110056617
Publisher
Nature Publishing Group
Year
2006
Tongue
English
Weight
96 KB
Volume
20
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tumor-primed natural killer cells from p
Tumor-primed natural killer cells from patients with multiple myeloma lyse autologous, NK-resistant, bone marrow-derived malignant plasma cells
✍ Eirini Katodritou; Evangelos Terpos; Janet North; Panagiotis Kottaridis; Evgenia 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

## Abstract Natural killer (NK) cells are cytotoxic lymphocytes able to kill tumor cells and virus‐infected cells. Human‐resting NK cells can be activated by co‐culture with NK‐resistant CTV‐1a cells. These tumor‐activated cells (TaNKs) are cytotoxic to a range of NK‐resistant tumor cells in vitro.

Expansion of natural killer cells in pat
Expansion of natural killer cells in patients with head and neck cancer: Detection of “noninhibitory” (activating) killer Ig-like receptors on circulating natural killer cells
✍ Giovanni Melioli; Claudia Semino; Giovanni Margarino; Paola Mereu; Marco Scala; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB 👁 1 views

## Background: In a group of patients with head and neck cancers (h&nc), the expansion of the population of cd3-,cd16+ natural killer (nk) cells in the peripheral blood was studied. ## Methods: Cytofluorimetric analysis of the expression of killer ig-like receptors (kir, namely p58.1, p58.2, p58.

Impaired expression and function of sign
Impaired expression and function of signal-transducing zeta chains in peripheral T cells and natural killer cells in patients with prostate cancer
✍ Cynthia G. Healy; Jonathan W. Simons; Michael A. Carducci; Theodore L. Deweese; 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 286 KB 👁 2 views

Detection of functional, circulating T cells and NK cells may serve as a clinical test for the selection of individuals who can benefit from immunotherapy. Incidence of the T-cell receptor zeta (TCRdelta) chain within these populations appears to correlate with adequate effector cell function. In pa